Reid Hoffman, the co-founder of LinkedIn and a prominent figure in Silicon Valley, is stepping down from Microsoft's board after a successful decade. His departure marks a significant shift as he aims to return to his entrepreneurial roots by focusing on his AI-driven drug discovery startup, Manas. Hoffman's decision underscores a growing trend among tech leaders who are increasingly pivoting towards innovative solutions in healthcare, particularly in the realm of artificial intelligence. With a wealth of experience and a strong network, Hoffman is poised to leverage his expertise to disrupt the pharmaceutical landscape through advanced AI technologies.
Source: TechCrunch
